India's Piramal Pharma up on launching in-vitro biology capabilities
** Shares of Piramal Pharma PIRM.NS rise as much as 4% to
100.8 rupees
** Pharmaceutical co launches in-vitro biology capabilities
at its Ahmedabad drug discovery site
** Nearly 2.2 mln shares change hands by 09:40 a.m. IST,
0.5x its 30-day avg
** Stock currently up 2.9%, trimming YTD losses to nearly
10%
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington